The use of cannabidiol as adjunctive therapy in adult patients with drug-resistant epilepsy: a systematic review and meta-analysis.

ABSTRACT:

Background

Highly purified cannabidiol (CBD), recently approved for various neurological disorders, is explored as a potential therapeutic avenue for drug-resistant epilepsy (DRE) among adult people with epilepsy (PWE) in this systematic review and meta-analysis.

Objectives

To conduct an extensive literature review and meta-analysis of CBD use for DRE in adult PWE.

Design

Systematic review and meta-analysis.

Data sources and methods

We conducted a systematic review of the literature according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and two electronic resources; we searched Ovid MEDLINE and Scopus using appropriate keywords until August 2023. Data were presented as standardized mean difference (SMD) and odds ratio wit

SUBMITTER: Ong MJY 

PROVIDER: S-EPMC11775975 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature